Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the group provides in-patient and out-patient medical services. Parent company operating a group that consolidates burn and plastic surgery subsidiary, established 2007.
Subsidiary of PSP Pharma (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 12,638 | 11,371 | 15,693 | 16,626 | 18,012 | 17,849 | 20,606 | 23,861 | +9.5% | |
| 52,983 | 78,843 | 89,620 | 86,974 | 86,455 | 88,086 | 89,407 | 91,269 | +8.1% | |
| TOTAL ASSETS | 65,620 | 90,213 | 105,313 | 103,600 | 104,467 | 105,935 | 110,014 | 115,131 | +8.4% |
| 3,587 | 7,008 | 13,045 | 16,507 | 17,844 | 18,111 | 19,304 | 17,439 | +25.3% | |
| 5,241 | 28,001 | 36,785 | 43,193 | 12,626 | 11,590 | 9,209 | 5,276 | +0.1% | |
| TOTAL LIABILITIES | 8,828 | 35,009 | 49,830 | 59,700 | 30,470 | 29,701 | 28,514 | 22,716 | +14.5% |
| 56,792 | 55,205 | 55,483 | 43,900 | 73,997 | 76,234 | 81,500 | 92,415 | +7.2% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 3,934 | 30,514 | 39,391 | 46,532 | 16,776 | 16,328 | 14,697 | 10,428 | +14.9% |
| Cash & Equivalents | 634 | 814 | 207 | 1,908 | 853 | 1,300 | 534 | 1,849 | +16.5% |
| Net Debt | 3,300 | 29,699 | 39,184 | 44,625 | 15,924 | 15,028 | 14,163 | 8,579 | +14.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →